RECENT UPDATE ON PYRIMIDINE DERIVATIVES AS POTENTIAL DPP-IV INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS. (2022). Journal of Pharmaceutical Negative Results, 5734-5743. https://www.pnrjournal.com/index.php/home/article/view/5581